Status:
COMPLETED
Early Two-dose Measles Vaccination Trial
Lead Sponsor:
Bandim Health Project
Collaborating Sponsors:
Danish Council for Development Research
Novo Nordisk A/S
Conditions:
Measles
Eligibility:
All Genders
4-6 years
Phase:
PHASE4
Brief Summary
The specific aims are to examine in Guinea-Bissau: * whether the standard titre Schwarz (SW) or standard-titre Edmonston-Zagreb (EZ) measles vaccine will be the best vaccine strain for use in a routi...
Detailed Description
BACKGROUND: Two dose schedules: After the failure of the high-titre measles vaccine, which was to be administered at 6 months of age it was suggested to perform trials of early two-dose measles vacc...
Eligibility Criteria
Inclusion
- Infants of 4½ months of age registered in the Bandim Health Project registration system and currently living in the Bandim Health Project areas: Bandim I, Bandim II, Belem, Mindará and Cuntum; and who received all three diphtheria-tetanus-pertussis vaccinations at least 4 weeks before enrollment
Exclusion
- Severe illness requiring immediate hospitalisation
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
5879 Patients enrolled
Trial Details
Trial ID
NCT00168558
Start Date
July 1 2003
End Date
March 1 2008
Last Update
March 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project
Bissau, Apartado 861, Guinea-Bissau, 1004 Bissau Codex